Login to Your Account



Proposed Part B price solutions put hospitals on defensive

By Mari Serebrov
Regulatory Editor

Monday, February 27, 2017

Although the American Hospital Association (AHA) is joining the biopharma pile-on over surging drug prices, some of its proposals to contain prices for Medicare Part B drugs line up with those touted by the drug industry itself.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription